Home » Topics » Science » Drug design, drug delivery and technologies

Drug design, drug delivery and technologies
RSS

Activated Cell Therapy's cell processing devices earn FDA approval

Aug. 30, 1996

Zyn-Linker shows promising results in preclinicals

Aug. 30, 1996

Data on Sterizone to be presented at scientific meeting

Aug. 23, 1996

Dynatronics/Life-Tech sign distribution agreement for iontophoresis products

Aug. 23, 1996

Organon and Signal sign drug development agreement

Aug. 23, 1996

Organon and Chiron sign research agreement

Aug. 23, 1996

Hereditary hemochromatosis gene discovered

Aug. 16, 1996

Aptamer-based PCR system to be codeveloped by NeXstar and Roche

Aug. 16, 1996

Neurocrine Biosciences receives SBIR grant for combinatorial chemistry technology

Aug. 16, 1996

European patent broadly protects Pharming's transgenic cattle generation technology

Aug. 9, 1996

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...